PAX - Pet Allergy Xplorer: The first molecular serum IgE specific test for pets
![big-PAX intro_Molecular allergy _1080x1080px_v2](https://hub.vetfamily.com/hubfs/big-PAX%20intro_Molecular%20allergy%20_1080x1080px_v2.webp)
![](https://hub.vetfamily.com/hubfs/Imported_Blog_Media/Picture1-Dec-13-2023-01-39-16-8966-PM-4.png)
Meet Nextview – Nextmune’s new customer portal
...
The future of IgE sensitisation detection - PAX® NOW AVAILABLE
From today, PAX® is officially available for the testing of dog sera....
![](https://hub.vetfamily.com/hubfs/Imported_Blog_Media/merge-1-1.png)
Nextmune enters partnership with biotechnology company Angany Inc.
Nextmune has signed an agreement to develop new vaccines for allergy and atopic dermatitis together with Angany, a...
![](https://hub.vetfamily.com/hubfs/Imported_Blog_Media/shutterstock_1446550646-4.jpg)
Revisit Veterinary Dermatology Webinars from Nextmune Education Week!
A month ago, as part of our Nextmune Academy initiative to share knowledge through educational events, we held the...
![](https://hub.vetfamily.com/hubfs/Imported_Blog_Media/Picture2-1-4.jpg)
Dr. Thierry Olivry's Point of View | March 2021
Sublingual immunotherapy also works in allergic cats! Dear Colleagues,...
![](https://hub.vetfamily.com/hubfs/Imported_Blog_Media/Picture%20nextmune-1.png)
Education Week, a huge success!
Nextmune Academy is official! We had a great kick off event in the first week of February, our Education Week was a...
![](https://hub.vetfamily.com/hubfs/Imported_Blog_Media/feb-Dec-21-2023-09-47-55-3780-AM.png)
Dr. Thierry Olivry's Point of View | February 2021
Does oclacitinib predispose dogs to develop cancer? Dear Colleagues,...
![](https://hub.vetfamily.com/hubfs/Imported_Blog_Media/Picture%20nextmune-Dec-21-2023-09-24-06-5477-AM.png)
Artuvet is now Nextmune!
The big moment is here… Artuvet is now NEXTMUNE And with a new name, a new logo, a new website, and much more to come!...
All posts